论文部分内容阅读
放免法测定地高辛（Digoxin）血药浓度是目前使用较广的方法，尤其适于基层医院。由于体内存在内源性地高辛样免疫活性物质（endogenousdigoxinlikeimmunoreactivesubstances,DLIS）与地高辛抗体有交叉反应；国外许多文献报道，新生儿、妊娠妇女、肾衰、肝损害及心血管疾病等病
Radioimmunoassay Digoxin plasma concentration is currently widely used, especially for primary hospitals. There is a cross-reaction between endogenous digoxin-like immunoreactive substances (DLIS) and digoxin antibody in vivo. Many foreign reports have reported that newborns, pregnant women, renal failure, liver damage and cardiovascular diseases